Overview

Hexarelin is a synthetic growth hormone-releasing peptide that binds and activates the growth hormone secretagogue receptor (GHSR) in the brain, like its natural analogue ghrelin. GHSR is also present in the heart and blood vessels, so hexarelin may have direct cardiovascular actions beyond GH release (Mao 2014). When compared with ghrelin, hexarelin is chemically more stable and functionally more potent (Mao 2014).

Receptors

Besides GHSR, the non-GHSR receptor CD36 has been shown to be a specific cardiac receptor for hexarelin and to mediate its cardioprotective effects (Mao 2014). Ghrelin and hexarelin are both ligands of the GHS receptor, with strong GH-releasing effects and stimulatory effects on prolactin and ACTH secretion, plus GH-independent cardiovascular activity. Hexarelin has been reported to regulate PPAR-gamma in macrophages and adipocytes (Mosa 2015).

FindingModelSource
Binds GHSR; CD36 is a specific cardiac receptor mediating cardioprotectionReviewMao 2014
Regulates PPAR-gamma in macrophages and adipocytes; GH-independent cardiovascular activityReviewMosa 2015
100 microg/kg/day for 7 days protected rat kidney from ischemia-reperfusion injury and reduced apoptosisRats and HK-2 cellsGuan 2023
200 microg/kg twice daily reduced aortic diameter and NF-kB signalling in aneurysmElastase mouse modelJiang 2022

Organ-protection findings in animals

In rats pretreated with hexarelin at 100 microg/kg/day for 7 days before ischemia-reperfusion, kidney injury, creatinine and apoptosis were reduced, with Bcl-2 up and Caspase-3, Bax and Bad down (Guan 2023). In an elastase-induced mouse aneurysm model, hexarelin at 200 microg/kg twice daily decreased infrarenal aorta diameter, improved elastin degradation, and inhibited NLRP3 inflammasome activation and NF-kB signalling (Jiang 2022).

What the sources do not show

  • The sources checked are reviews and animal studies. They do not compare hexarelin with GHRP-2 or GHRP-6 directly.
  • For GH release data in humans see the GHRP-2 and GHRP-6 comparison, which cites human studies of hexarelin and GHRP-2.
  • No source checked gives storage or stability data for hexarelin.

Related research products and tools

Frequently Asked Questions

What does hexarelin bind?

The growth hormone secretagogue receptor (GHSR), and CD36 as a specific cardiac receptor (Mao 2014).

How does it compare with ghrelin?

It is described as chemically more stable and functionally more potent (Mao 2014).

What was studied in animals?

Kidney ischemia-reperfusion injury in rats and aortic aneurysm in mice (Guan 2023, Jiang 2022).

Key References

  • Mao Y, et al. The cardiovascular action of hexarelin. J Geriatr Cardiol. 2014. PubMed 25278975
  • Mosa RM, et al. Implications of ghrelin and hexarelin in diabetes and diabetes-associated heart diseases. Endocrine. 2015. PubMed 25645463
  • Guan C, et al. Hexarelin alleviates apoptosis on ischemic acute kidney injury via MDM2/p53 pathway. Eur J Med Res. 2023. PubMed 37710348
  • Jiang B, et al. Hexarelin attenuates abdominal aortic aneurysm formation by inhibiting SMC phenotype switch and inflammasome activation. Microvasc Res. 2022. PubMed 34856183

For research use only. Not for human consumption.